id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-P-6045-0021,FDA,FDA-2019-P-6045,Final Response Letter from FDA CFSAN to Hyman Phelps and McNamara PC,Other,Response(s),2022-04-27T04:00:00Z,2022,4,2022-04-27T04:00:00Z,,2022-04-27T14:10:06Z,,0,0,0900006485039ba1